The global Vitamin Yeast Market is valued at $1.2 billion in 2024 and is projected to reach $2.4 billion by 2034, growing at a CAGR of 7.2%.

On March 7, 2025, Exactitude Consultancy., Ltd. released a research report titled “Vitamin Yeast Market” This report offers a new perspective on the Vitamin Yeast Market covering an extensive range of aspects including market overview, expenditure analysis, import trends, segmentation, key players, and opportunities spanning. The analysis delves into a thorough competitive assessment of major market participants, presenting their corporate profiles, noteworthy insights into product and business offerings, recent advancements, and pivotal market strategies. It also forecasts the market size of automotive kick sensors based on market patterns from 2025 to 2034 and future market trends. Along with quantitative data, this study also provides qualitative analysis for companies to formulate growth strategies, evaluate the competitive environment, and analyze their market positions.

This report is also available in the following languages: Japanese (ビタミン酵母市場), Korea (비타민 효모 시장), china (维生素酵母市场), French (Marché de la levure vitaminée), German (Markt für Vitaminhefe), and Italy (Mercato del lievito vitaminico), etc.

For comprehensive analysis and detailed insights Get Sample PDF Report @

https://exactitudeconsultancy.com/reports/47671/vitamin-yeast-market#request-a-sample

📌 Key players analysed in the industry report include:

Red Star Yeast, Strength Foods, Saf Pro Instant Yeast, Lesaffre, BioCare Copenhagen, Yeast and Co., Baker’s Authority, S. M. J. International, Angel Yeast Co., Ltd., Nutritional Supplements, LLC, All American Spices, Ginkgo BioWorks, AB Mauri, Pak Group, Sigma Aldrich, Cargill, Incorporated, Kerry Group, Nisshin Seifun Group, Chr. Hansen, DSM Nutritional Products

Segmentation of Market

Type:

– Nutritional Yeast

– Baker’s Yeast

– Brewer’s Yeast

– Form:

– Powder

– Flakes

– Capsules/Tablets

– End-Use Industry:

– Food & Beverage

– Pharmaceuticals

– Animal Feed

– Dietary Supplements

– Distribution Channel:

– Online Retail

– Offline Retail

– Supermarkets/Hypermarkets

– Specialty Stores

This Market report studies the top producers and consumers, focuses on product capacity, value, consumption, market share, and growth opportunity in these key regions, covering

North America (the United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Spain, Italy, and Others)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of APAC)

South America (Brazil, Argentina, Colombia, etc.)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

We Offer Customized Report, Click @:

https://exactitudeconsultancy.com/reports/47671/vitamin-yeast-market

Chapter Outline:

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: key insights, key emerging trends, etc.

Chapter 3: Manufacturers competitive analysis, detailed analysis of Vitamin Yeast Market manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 5 & 6: Revenue of Vitamin Yeast Market in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: The main points and conclusions of the report.

Buy Now Report:

https://exactitudeconsultancy.com/purchase/?currency=USD&type=single_user_license&report_id=47671

Reasons to Purchase the Report:

👉 Strategic Competitor Insights: Gain critical information and analysis on key competitors to develop effective sales and marketing strategies.

👉 Identify Emerging Players: Discover new entrants with promising product portfolios and formulate counter-strategies to enhance your competitive edge.

👉 Target Client Identification: Classify potential new clients or partners within your target demographic for better market penetration.

👉 Tactical Initiative Development: Understand the focal areas of leading companies to craft informed tactical initiatives.

👉 Mergers and Acquisitions Planning: Make strategic decisions regarding mergers and acquisitions by pinpointing top manufacturers in the market.

👉 Licensing Strategy Development: Identify prospective partners with attractive projects to create robust in-licensing and out-licensing strategies, thereby enhancing business potential.

👉 Support for Presentations: Utilize reliable, high-quality data and analysis to strengthen your internal and external presentations.

customization:

can I modify the scope of the report and customize it to suit my requirements?

-Yes. Customized requirements of multi-dimensional, deep-level, and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus winning them sufficient time and space for market competition.

– 20% customization.

– 5 Countries can be added as per your choice.

– 5 Companies can add as per your choice.

– Free customization for up to 40 hours.

– After-sales support for 1 year from the date of delivery.

Check out our trending studies to understand industry shifts :

https://pr.gulfmainmagazine.com/article/Optical-Imaging-Market-Set-to-Surge-from-dollar141-Billion-in-2023-to-dollar232-Billion-by-2033-Driven-by-Advancements-in-Medical-Diagnostics-or-Exactitude-Consultancy?storyId=66a1ddd5709b0518e413724c

https://www.alabamabusinessreporter.com/article/730626086-airport-information-systems-market-is-projected-to-grow-to-usd-5-23-billion-by-2032-exactitude-consultancy

https://smb.atmoreadvance.com/article/Micro-and-Mini-LED-Display-Market-is-expected-to-be-valued-at-USD-1332-billion-by-2033-or-Exactitude-Consultancy?storyId=66a3666a709b0518e43ec199

http://www.economypressreleases.com/article/731274566-fiberglass-market-is-expected-to-be-valued-at-usd-23-19-billion-by-2032-exactitude-consultancy

Ehttps://www.rhodeislandbusinessdaily.com/article/731294842-rf-probe-card-market-is-expected-to-be-valued-at-usd-4-360-97-million-by-2033-exactitude-consultancy

https://www.consumerproductstimes.com/article/731583310-multirotor-drones-market-is-expected-to-be-valued-at-usd-10-15-billion-by-2029-exactitude-consultancy

https://pr.thembnews.com/article/Zinc-Chemicals-Market-is-expected-to-be-valued-at-USD-4104-billion-by-2033-or-Exactitude-Consultancy?storyId=66acd6d1709b0518e44e4ffd

https://pr.holladayjournal.com/article/Air-Ambulance-Market-exhibiting-a-CAGR-of-105percent-during-the-forecast-period-Exactitude-Consultancy?storyId=667e5df1abafe09975ea1b6b

https://www.theasiagazette.com/article/733380032-toluene-market-is-expected-to-be-valued-at-usd-66-27-billion-by-2033-exactitude-consultancy

https://www.globalfinanceobserver.com/article/733995061-membrane-separation-technology-market-is-expected-to-be-valued-at-usd-84-13-billion-by-2033-exactitude-consultancy

Explore More: Visit Our Website for Additional Reports

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://exactitudeconsultancy.com/

About Us:

Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.

Contact Us:

Exactitude Consultancy

PHONE NUMBER +1 (704) 266-3234

EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.

Research Highlights:

• Higher levels of the minerals copper and manganese in pregnant women were associated with lower blood pressure and a reduced risk of developing high blood pressure decades later, according to a long-term study of women in Massachusetts.
• Higher levels of vitamin B12 were also associated with lower blood pressure in midlife.
• Note: The study featured in this news release is a research abstract presenting at the American Heart Association’s Epidemiology, Prevention, Lifestyle and Metabolic Health Scientific Sessions 2025, and the full manuscript is simultaneously published in the American Heart Association’s peer-reviewed journal Hypertension.

Embargoed until 3 p.m. CT/4 p.m. ET, Thursday March 6, 2025

NEW ORLEANS, March 6, 2025 — Women with higher levels of essential minerals circulating in their blood during pregnancy, particularly copper and manganese, along with vitamin B12, had a lower risk of developing high blood pressure in middle age, about 20 years later, according to research presented at the American Heart Association’s Epidemiology and Prevention | Lifestyle and Cardiometabolic Health Scientific Sessions 2025. The meeting will be held in New Orleans, March 6-9, 2025, and offers the latest science on population-based health and wellness and implications for lifestyle. According to the study authors, it is the first to explore the associations of pregnancy metal levels with women’s midlife blood pressure and hypertension risk, and the full manuscript is simultaneously published today in the American Heart Association’s peer-reviewed journal Hypertension.

Manganese, selenium, magnesium and copper are among the essential metals important for a healthy body because their anti-oxidation and anti-inflammatory properties may help protect against cardiovascular disease. Previous research has found that higher levels of manganese were associated with a lower risk of preeclampsia (high blood pressure during pregnancy). However, it is not known whether higher levels of essential metals during pregnancy may influence the risk of developing high blood pressure later in life. Additionally, chronic exposure to the non-essential metals lead, cadmium and arsenic is associated with an increased risk of cardiovascular disease, according to the Association’s 2023 scientific statement “Contaminant Metals as Cardiovascular Risk Factors.“

“People are constantly exposed to heavy metals and trace elements, and much research has shown that exposure to those metals and elements may have an impact on cardiovascular health, especially hypertension,” said lead study author Mingyu Zhang, Ph.D., M.H.S., an epidemiologist and instructor in medicine at Beth Israel Deaconess Medical Center and Harvard Medical School, both in Boston. “In our study, we wanted to examine how levels of essential metals and elements during pregnancy may affect blood pressure and hypertension risk in midlife.”

The researchers analyzed data from Project Viva, an ongoing, long-term study that began in 1999 of women and their children who live in eastern Massachusetts. Nearly 500 women enrolled in the study during early pregnancy, between 1999 and 2002. Researchers measured concentrations of non-essential metals (arsenic, barium, cadmium, cesium, mercury and lead), essential minerals (copper, magnesium, manganese, selenium and zinc), folate and vitamin B12 in blood samples collected during study enrollment.

After nearly twenty years of follow-up, researchers conducted a “midlife” study visit between 2017 and 2021 with the same study participants, who were now at a median age of 51.2 years. Researchers measured blood pressure to assess potential associations of individual metals with blood pressure and high blood pressure risk. Participants were categorized as having high blood pressure if blood pressure measures were greater than 130/80 mm Hg or if participants confirmed taking anti-hypertensive medication. In addition, the potential collective effects of all eleven metals and two micronutrients on blood pressure were analyzed.

The study found:

• After researchers adjusted for sociodemographic factors, as levels of copper and manganese doubled in the blood during pregnancy, the risk of high blood pressure in midlife was 25% and 20% lower, respectively.
• As blood levels of vitamin B12 doubled during pregnancy, women had an average 3.64 mm Hg lower systolic blood pressure and 2.52 mm Hg lower diastolic blood pressure almost two decades later. About 95% of the study participants had vitamin B12 levels within the normal range, the researchers noted.
• Blood levels of the mixture of copper, manganese, selenium and zinc were also associated with lower blood pressure in a relationship that increased with dose. Nonessential metals did not have a significant impact on blood pressure.

“Circulating levels of these metals and minerals in blood were measured, however, the sources of exposure, such as food or dietary supplements, were not quantified so these findings should not be interpreted as recommendations,” Zhang said. “Optimizing these essential metals, minerals and vitamins, particularly copper, manganese and vitamin B12, during pregnancy may offer protective benefits against hypertension in midlife, an especially critical time period for women’s future cardiovascular risk in later life.”

“More research including clinical trials is needed to determine the optimal dietary intake of these minerals and micronutrients,” he added. The researchers hope to ultimately identify women at high risk for developing high blood pressure later in life and intervene during pregnancy, either with enhanced nutrition or supplements.

 Study details, background and design:

• The analysis included 493 women enrolled in Project Viva, a prospective study examining the effects of environmental and lifestyle factors during pregnancy on the short and long-term health of women and their children.
• Project Viva enrolled women in early pregnancy between 1999 and 2002. The women had a median age of 32.9 years at enrollment. Participants were followed for 18.1 years, through 2021.
• 72% of participants self-identified as white women; 11% were self-identified as Black women; and 17% self-identified as Hispanic or Latina, Asian or Pacific Islander, American Indian or Alaskan Native, or selected “Other” race, more than one race or “do not know.”
• Blood samples were collected at study enrollment and stored in freezers for subsequent analyses. The researchers accessed blood samples and analyzed them for this study in 2018. Folate and vitamin B12 were also measured in blood plasma samples during pregnancy.
• Blood pressure was measured in study participants during a “midlife” (median age of 51 years) study visit between 2017 and 2021. During this visit, trained research assistants measured participants’ blood pressure up to five times, at one-minute intervals. Blood pressure measurements were then averaged.
• The analyses were adjusted for maternal age at study enrollment, pre-pregnancy body mass index, race and ethnicity, education, household income, parity (the number of pregnancies carried to term), use of anti-hypertensive medication, DASH diet score in early pregnancy and multivitamin intake.

The study’s limitations include that it was an observational study, meaning other confounding factors that were not measured in the study may have affected the results; the researchers only included a subset of the original Project Viva participants; and there were demographic differences between participants included and excluded. In addition, the researchers did not have measurements for metal levels between delivery and midlife; and participants were predominantly white women who resided in Eastern Massachusetts, which may limit the generalizability of the study’s findings.

Poster Presentation P3082 in Session PS03.07 Hypertension 2 is Saturday, March 8, 2025 at 5:00 p.m. CT.

Co-authors, disclosures and funding sources are listed in the manuscript.

Statements and conclusions of studies that are presented at the American Heart Association’s scientific meetings are solely those of the study authors and do not necessarily reflect the Association’s policy or position. The Association makes no representation or guarantee as to their accuracy or reliability. Abstracts presented at the Association’s scientific meetings are not peer-reviewed, rather, they are curated by independent review panels and are considered based on the potential to add to the diversity of scientific issues and views discussed at the meeting. The findings are considered preliminary until published as a full manuscript in a peer-reviewed scientific journal.

Studies published in the American Heart Association’s scientific journals are peer-reviewed. The statements and conclusions in each manuscript are solely those of the study authors and do not necessarily reflect the Association’s policy or position. The Association makes no representation or guarantee as to their accuracy or reliability.

The Association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific Association programs and events. The Association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and biotech companies, device manufacturers and health insurance providers and the Association’s overall financial information are available here.

Additional Resources:

###

The American Heart Association’s EPI | Lifestyle Scientific Sessions 2025 is the world’s premier meeting dedicated to the latest advances in population-based science. The meeting is Thursday through Sunday, March 6-9, 2025, at the Hyatt Regency in New Orleans. The primary goal of the meeting is to promote the development and application of translational and population science to prevent heart disease and stroke and foster cardiovascular health. The sessions focus on risk factors, obesity, nutrition, physical activity, genetics, metabolism, biomarkers, subclinical disease, clinical disease, healthy populations, global health, and prevention-oriented clinical trials. The Councils on Epidemiology and Prevention and Lifestyle and Cardiometabolic Health (Lifestyle) jointly planned the EPI | Lifestyle Scientific Sessions2025. Follow the conference on X at #EPILifestyle25.

About the American Heart Association

The American Heart Association is a relentless force for a world of longer, healthier lives. Dedicated to ensuring equitable health in all communities, the organization has been a leading source of health information for more than one hundred years. Supported by more than 35 million volunteers globally, we fund groundbreaking research, advocate for the public’s health, and provide critical resources to save and improve lives affected by cardiovascular disease and stroke. By driving breakthroughs and implementing proven solutions in science, policy, and care, we work tirelessly to advance health and transform lives every day. Connect with us on heart.org, Facebook, X or by calling 1-800-AHA-USA1.

For Media Inquiries and AHA/ASA Expert Perspective: 

AHA Communications & Media Relations in Dallas: 214-706-1173; ahacommunications@heart.org

John Arnst: John.Arnst@heart.org

For Public Inquiries: 1-800-AHA-USA1 (242-8721)

heart.org and stroke.org